Blocknomi
Key Takeaways Eli Lilly shares climbed over 4% during early Monday session following weekend disclosure of promising clinical trial results. The company’s investigational obesity medication retatrutide demonstrated a 60.6% reduction…
Related articles
-
Ethereum (ETH) Struggles Below $1,700: Key Technical Levels to Watch
Blocknomi Published 13.06.2026 09:42
-
US Investors’ Equity Exposure Tops Levels Seen Before Past Bear Markets
BeInCrypto Published 16.06.2026 05:31
-
SHIB Team Issues Update as Shiba Inu Website Faces Temporary Disruption
U.Today Published 07.06.2026 09:44
-
Crypto Could Still Catch Up After Iran De-Escalation Sparks Global Market Rally: Data
CryptoPotato Published 12.06.2026 08:31
-
Anthropic Suspends Fable 5 and Mythos 5 After US Government Issues Export Control Directive
Blocknomi Published 13.06.2026 21:07
-
Resurfaced Elon Musk Video: I Won’t Promote Crypto but Have a Soft Spot for Dogecoin
The Crypto Basic Published 15.06.2026 09:21
-
DTCC And Stellar Plan Tokenization Link For DTC-Custodied Assets
NewsBTC Published 16.06.2026 23:04
-
Binance bStocks push heats up after $143M equities debut
Crypto.News Published 15.06.2026 11:25